The annual production capacity of Sinopharm’s new crown vaccine will reach 3 billion doses. Yu Qingming, deputy to the National People’s Congress and chairman of Sinopharm holdings of Sinopharm group, said “several times” about Sinopharm’s new crown vaccine

When can people under 18 be vaccinated? Yu Qingming: on February 25, Sinopharm Wuhan Institute of biology approved the conditional marketing of Xinguan inactivated vaccine, which is suitable for people aged 18 and above

.

In case of infringement, please contact us for deletion

.

3

.

After the data were submitted to the State Food and Drug Administration for approval, it would be used in the 3-17-year-old people

.

In which countries has Sinopharm Xinguan vaccine been approved for marketing? Yu Qingming: Sinopharm China new crown vaccine has been registered and listed in five countries

.

In addition, more than 80 countries and international organizations have put forward a clear demand for the use of Sinopharm new crown vaccine

.

The new coronavirus vaccine is a newly developed and put into use vaccine

.

After one year of continuous follow-up and monitoring of antibodies, the antibodies are still at a high level, and there is no obvious decline

.

What is the protection rate of Sinopharm Xinguan vaccine and is it effective for mutated virus? Yu Qingming: the data of large-scale overseas clinical trials approved by various governments show that Sinopharm Xinguan vaccine has 86% protective effect, 99% neutralizing antibody positive conversion rate, 100% effectiveness in preventing moderate cases and 100% effectiveness in preventing severe cases

.

The five countries that ratified the treaty are the United Arab Emirates, Bahrain, China, Bolivia and Seychelles

.

How many countries in the world use Sinopharm new crown vaccine? Are there any serious adverse reactions? Yu Qingming: up to now, 40 countries and regions have approved the emergency use of Sinopharm China Biological New Crown vaccine

.

5

.

In addition, the phase III clinical trial data of 3-17-year-old people showed that Sinopharm China Bio new crown inactivated vaccine was safe and effective

.

“More than 5000 representatives and members of the national” two sessions “have been vaccinated with Sinopharm China Bio new crown vaccine, which reflects the high trust in Sinopharm vaccine.” Yu Qingming, deputy to the National People’s Congress, Secretary of the Party committee and chairman of Sinopharm holdings, told people’s daily health

.

It needs continuous monitoring and related research after mass vaccination to accumulate more scientific evidence in order to accurately evaluate the protection persistence of the new coronavirus vaccine

.

6

.

The annual production capacity of Xinguan vaccine will reach 3 billion doses, making it the largest manufacturer of Xinguan vaccine in the world

.

2

.

The results of recent cross neutralization test showed that Sinopharm new coronavirus vaccine had broad-spectrum protective effect on 10 new coronavirus mutants in South Africa and the United Kingdom, which could effectively prevent the infection caused by the mutants

.

What is the annual production capacity of Sinopharm Xinguan vaccine to meet domestic demand for export? Yu Qingming: Sinopharm Group continues to expand its production capacity

.

The contents and articles of this official account are purely personal views of the author, which are for reference only.

.

4

.

1

.

Good news: new crown vaccine may be born?! University of pharmacy | China Pharmaceutical University recruitment notice for Dean of School of pharmacy | clinical CRA / SCRA content source network, all rights reserved by the original author

.

How long is the protection period of Sinopharm Xinguan vaccine? Yu Qingming: in March 2020, the person in charge of the party and government of the fourth level enterprise of Sinopharm group was vaccinated

.

So far, Sinopharm sinobio has approved two new crown inactivated vaccines to be listed, and is the only company with “double insurance” of new crown vaccine in the world

.

Among them, Serbia is the first European country and Hungary is the first European Union country

.

No serious adverse reactions related to the vaccine have been found

.

In February 25th, the State Drug Administration attached the New Coronavirus inactivated vaccine (Vero cell) of the National Biological Products Research Institute of Wuhan, China

.

It is not only the first new crown vaccine officially registered and listed in the world, but also the only new crown vaccine approved and listed in many countries

.

Yu Qingming, chairman of the board of directors of the board of directors of the board of directors of the board of directors of the board of directors of the board of directors of the board of directors of the board of directors of the board of directors of the board of directors of the board of directors of the board of directors of the board of directors of the board of directors of the board of directors of the board of directors of the

.

On the basis of the P3 high-level biosafety production workshop of Beijing Institute of biological products and Wuhan Institute of biological products, we will continue to expand the production capacity and sub packaging capacity of our six major biological products research institutes, including Changchun, Shanghai, Lanzhou and Chengdu, and fully demonstrate the role of the national team, main force and pillar of the central enterprises

.

Sinopharm has supplied nearly 100 million doses of new crown vaccine at home and abroad, and has been vaccinated more than 60 million times

.

At present, the oldest vaccinator is nearly 100 years old

.